Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid + Vidaza in Relapsed/Refractory CLL/SLL
NCT01241786Phase 2Terminated
- Sponsor
- Hackensack Meridian Health
- Start
- Jul 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide, azacitidine in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by Hackensack Meridian Health. Started Jul 2010; status: terminated.
02
Drugs
lenalidomideazacitidine
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT01241786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01241786.